Literature DB >> 17401142

The C terminus of apolipoprotein A-V modulates lipid-binding activity.

Jennifer A Beckstead1, Kasuen Wong, Vinita Gupta, Chung-Ping L Wan, Victoria R Cook, Richard B Weinberg, Paul M M Weers, Robert O Ryan.   

Abstract

Human apolipoprotein A-V (apoA-V) is a potent modulator of plasma triacylglycerol (TG) levels. To probe different regions of this 343-amino-acid protein, four single Trp apoA-V variants were prepared. The variant with a Trp at position 325, distal to the tetraproline sequence at residues 293-296, displayed an 11-nm blue shift in wavelength of maximum fluorescence emission upon lipid association. To evaluate the structural and functional role of this C-terminal segment, a truncated apoA-V comprising amino acids 1-292 was generated. Far UV circular dichroism spectra of full-length apoA-V and apoA-V-(1-292) were similar, with approximately 50% alpha-helix content. In guanidine HCl denaturation experiments, both full-length and truncated apoA-V yielded biphasic profiles consistent with the presence of two structural domains. The denaturation profile of the lower stability component (but not the higher stability component) was affected by truncation. Truncated apoA-V displayed an attenuated ability to solubilize l-alpha-dimyristoylphosphatidylcholine phospholipid vesicles compared with full-length apoA-V, whereas a peptide corresponding to the deleted C-terminal segment displayed markedly enhanced kinetics. The data support the concept that the C-terminal region is not required for apoA-V to adopt a folded protein structure, yet functions to modulate apoA-V lipid-binding activity; therefore, this concept may be relevant to the mechanism whereby apoA-V influences plasma TG levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401142     DOI: 10.1074/jbc.M611797200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.

Authors:  Kasuen Wong-Mauldin; Vincent Raussens; Trudy M Forte; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

Review 2.  Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlement.

Authors:  Vineeta Sharma; Robert O Ryan; Trudy M Forte
Journal:  Biochim Biophys Acta       Date:  2011-12-22

Review 3.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

4.  Apolipoprotein-induced conversion of phosphatidylcholine bilayer vesicles into nanodisks.

Authors:  Chung-Ping Leon Wan; Michael H Chiu; Xinping Wu; Sean K Lee; Elmar J Prenner; Paul M M Weers
Journal:  Biochim Biophys Acta       Date:  2010-11-25

5.  The carboxyl-terminal segment of apolipoprotein A-V undergoes a lipid-induced conformational change.

Authors:  Kasuen Mauldin; Brian L Lee; Marta Oleszczuk; Brian D Sykes; Robert O Ryan
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

6.  Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.

Authors:  Mao Koyama; Masafumi Tanaka; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

7.  Intracellular lipid droplet targeting by apolipoprotein A-V requires the carboxyl-terminal segment.

Authors:  Xiao Shu; Robert O Ryan; Trudy M Forte
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

Review 8.  Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol.

Authors:  Vineeta Sharma; Trudy M Forte; Robert O Ryan
Journal:  Curr Opin Lipidol       Date:  2013-04       Impact factor: 4.776

9.  The ins (cell) and outs (plasma) of apolipoprotein A-V.

Authors:  Trudy M Forte; Xiao Shu; Robert O Ryan
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

10.  Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I.

Authors:  John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2008-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.